Allarity Therapeutics, Inc.
ALLR
$1.52
-$0.16-9.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.23M | -15.31M | -24.10M | -23.40M | -24.52M |
| Total Depreciation and Amortization | -13.00K | -20.00K | 29.00K | 18.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.10M | 581.00K | 10.06M | 7.72M | 7.09M |
| Change in Net Operating Assets | -5.68M | -33.00K | -2.81M | -2.97M | 63.00K |
| Cash from Operations | -14.82M | -14.78M | -16.82M | -18.64M | -17.35M |
| Capital Expenditure | -8.00K | -298.00K | -298.00K | -298.00K | -298.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.00K | -298.00K | -298.00K | -298.00K | -298.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 1.34M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -1.34M | -1.34M |
| Issuance of Common Stock | 13.84M | 17.83M | 20.81M | 48.46M | 37.35M |
| Repurchase of Common Stock | -3.19M | -2.71M | -2.57M | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 2.94M | 2.94M | 2.94M |
| Repurchase of Preferred Stock | -- | 0.00 | -3.50M | -3.50M | -3.50M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.65M | 15.12M | 17.68M | 46.56M | 36.79M |
| Foreign Exchange rate Adjustments | -667.00K | -1.61M | -2.00M | -226.00K | 225.00K |
| Miscellaneous Cash Flow Adjustments | 1.00K | -- | -- | -- | -- |
| Net Change in Cash | -4.85M | -1.57M | -1.43M | 27.39M | 19.37M |